Skip to main content

LYRA

Lyra Therapeutics, Inc.

Company with tickers: LYRA

CIK
1327273
CUSIP
55234L204
Shares Outstanding
1,774,882
13F Activity (30d)
3 filings 2 filers

Transcripts of the company's quarterly earnings conference calls, where management reviews results and answers analyst questions.

Showing 1–5 of 5 transcripts